SAEM20 Presentation Titles | Presenting Authors |
Trends in Opioid Exposures Following Hydrocodone Rescheduling | H. Nguyen, MD J.A. Chenoweth, MD, MAS |
Frequency of multiple Opioid Overdoes per Individual in Connecticut During Seven Month Period | Peter Canning Suzanne Doyon Katherine Hart, MD Richard Kamin, MD Mary Kosciusko |
Incidence of Opioid Overdoses in Motor Vehicles in Connecticut | Peter Canning Suzanne Doyon Katherine Hart, MD Richard Kamin, MD Mary Kosciusko |
Comparative Effectiveness of Two Individualized Acute Pain Treatment Communication Tools | Zachary Meisel, MD, MPH, MSHP |
Violent Crime Commission After Discharge May Be Preventable | Joshua Finkel Zachary DW Dezman, MD, MS Kinjal Sethuraman, MD, MPH Laura Buchanan, MD |
ED Pts w/ Untreated OUD in 4 Cities A Comparison of Those Seeking VS Not Seeking Addiction Treatment | Edouard Coupet, Jr., MD, MS |
Adverse Respiratory Effects Following Medications for Opioid Use Disorder (MOUD) - approved buprenorphine oral exposures; National Poison Data System 2003-2019 | Mike Durracq, MD, MPH |
Interrupted Time Series of User-Centered Clinical Decision Support Impementation for Emergency Department-Initiated Buprenorphine for Opioid Use Disorder | Wesley C. Holland, BS Bidisha Nath, MD, MPH Fangyong Li, MPH Kaitlin Maciejewski, MS Hyung Paek, MD James Dziura, PhD Haseena Rajeevan, PhD Charles C Lu, MS Liliya Katsovich, MS, MBA Gail D'Onofrio, MD, MS Edward R. Melnick, MD, MHS |
Opioid Stewardship Program Integrating Simulation Based Training with Standardized Patients | Michael Lamberta, MD Amish Aghera, MD Sergey Motov, MD Nubaha Elahi, MD Reuben Strayer, MD |
Evaluation of race and ethnicity as barriers to inpatient treatment for opioid use disorder | Jessica Faiz, MD Ed Bernstein, MD Julianne Dugas, MPH Elissa M. Schechter-Perkins, MD, MPH Lauren Nentwich, MD Kerrie P. Nelson, PhD Joseph R. Pare, MD, MHS |
Emergency Department SBIRT Improves Identification of At-Risk Patients | Margaret Carlson, MPH |
Feasibility and Impact of Implementing Buprenorphine Initiation Programs in Three Heterogenous Rural and Urban EDs | Ryan McCormack John Rotrosen Gail D'Onofrio Phoebe Gauthier Lisa Marsch Abigail Matthews Caroline Mulatya E. Jennifer Edelman Sarah Farkas David Fiellin William Goodman Kristen Huntley Randolph Knight David Liu Sarah Meyers-Ohki Patricia Novo Soo-Min Shin Stephen Wall Kathryn Hawk |
Demystifying & Destigmatizing ED Initiated Buprenorphine: A Standardized Experiential Faculty Development | Daniel Lugassy, MD Ryan P. McCormack, MD, MS Soo-Min Shin, MA Sondra Zabar, MD Ann Nguyen, PhD, MPH Zelda Moran, MPH Philip DiSalvo, MD |
Exploring Barriers to Implementing an Emergency Medical Services Naloxone Leave Behind Program | Daniel Duk Rebecca Martin, MD, PhD Jenny Holcombe, PhD Ron Buchheit, MD Jessica Whittle, MD, PhD Sudave Mendiratta, MD |
Metabolomic Markers Predictive of Adverse Events Due to Acetaminophen Administration | Brandon Sonn, MS |
Metabolomic Markers Predictive of Adverse Events Due to Acetaminophen Administration | Brandon Sonn, MS Kennon Heard, MD, PhD Susan Heardl Angelo D'Alessandro, PhD Barry Rumack, MD Andrew Monte, MD, PhD |
A Novel Metric for Identifying Naloxone Distribution from the ED in High-Risk Patients | Manuel Celedon MD Zahir Basrai MD Jonie Hsiao MD Neil Patel MD Chad Kay BS Michael Harvey PharmD Melissa Christopher PharmD |
Emergency Department Utilization Patters in Patients with Opioid-Related ED Visits | Siri Shastry Evan Shegog George Loo Ethan Cowan |
Efficacy of Topical Capsaicin for the Treatment of Cannabinoid Hyperenesis Syndrome | Yusuf H. Geier Staidle A. Montoy JC |
No Change in the Use of Antivenom in Ohio for Treatment of Copperhead Bites | Walker Plash, MD Uwe Stolz, PhD, MPH Sheila Goertemoeller, PharmD Edward Otten, MD |
Recreational Cannabis Legalization and Exposures in Children | Walter Palmer, MD Alisa McQueen, MD Michael S. Wah |